26Aug
Financial Daily Dose 8.26.2019 | Top Story: Amgen to Pay More Than $13 Billion for Otezla
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....
By:
Robins Kaplan LLP
Related
Special series focused on the impact of the COVID-19 pandemic on the Aerospace, Defense, and Governm...
Read More >
On Friday, January 31, 2020, Chief District Judge Kimberly J. Mueller of the federal District Court ...
Read More >
Many federal construction contractors have been there: it’s near the end of the project and the gov...
Read More >
President Vladimir Putin signed a package of laws (informally referred to as the Investment Code) on...
Read More >
Frazier Healthcare Partners has announced it has acquired Accuity Delivery Systems....By: McGuireWoo...
Read More >
In Nemchin v. Green, the Court of Appeal for Ontario clarified a number of important aspects of the ...
Read More >